[SGMO] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
04-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 95.69%
YoY- 94.32%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 9,398 26,460 28,563 57,763 21,958 23,562 11,812 -3.73%
PBT -102,893 -53,125 -47,602 -1,271 -27,361 -12,843 -12,354 42.35%
Tax 1,270 30 86 237 -54 0 0 -
NP -104,163 -53,155 -47,688 -1,550 -27,307 -12,843 -12,354 42.64%
Tax Rate - - - - - - - -
Total Cost 113,561 79,615 76,251 59,313 49,265 36,405 24,166 29.40%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -1,108.35 -200.89 -166.96 -2.68 -124.36 -54.51 -104.59 48.17%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.59 -0.34 -0.33 -0.01 -0.24 -0.13 -0.15 25.62%
EPS Diluted -0.59 -0.34 -0.33 -0.01 -0.24 -0.13 -0.15 25.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.